September 6, 2022 — Stopping statin treatment early could substantially reduce lifetime protection against heart disease ...
September 6, 2022 — Smokers have weaker hearts than non-smokers, according to research presented at ESC Congress 2022.1 ...
September 6, 2022 — Research presented at ESC Congress 2022 supports a causal relationship between air pollution and ...
September 2, 2022 — A restrictive oxygenation target in comatose patients resuscitated after out-of-hospital cardiac ...
September 2, 2022 — Dapagliflozin reduces the risk of cardiovascular death or worsening heart failure in heart failure ...
September 2, 2022 — Acetazolamide added to intravenous loop diuretics decreases congestion within three days in patients ...
September 2, 2022 — A randomized trial in more than 45,000 men has suggested that cardiovascular screening including car ...
September 2, 2022 — In an innovative, pragmatic randomized trial, high-dose influenza vaccination in older adults was ...
September 2, 2022 — In patients undergoing echocardiographic evaluation of cardiac function, preliminary assessment by a ...
September 2, 2022 — Percutaneous coronary intervention (PCI) does not reduce all-cause mortality or heart failure hospit ...
September 1, 2022 — “At ESC Congress in Barcelona, we discussed the newest science in the light of our collective ...
September 1, 2022 — A target blood pressure of 77 mmHg provides no benefit to survival or neurological outcome in ...
September 1, 2022 — The gout medicine allopurinol has failed to reduce the primary endpoint of nonfatal myocardial ...
August 30, 2022 — Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, will showcase its latest ...
August 30, 2022 — A pill containing aspirin and medications to lower lipids and blood pressure more effectively prevents ...